Cargando…
Antioxidant and Metal Chelation-Based Therapies in the Treatment of Prion Disease
Many neurodegenerative disorders involve the accumulation of multimeric assemblies and amyloid derived from misfolded conformers of constitutively expressed proteins. In addition, the brains of patients and experimental animals afflicted with prion disease display evidence of heightened oxidative st...
Autores principales: | Brazier, Marcus W., Wedd, Anthony G., Collins, Steven J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665489/ https://www.ncbi.nlm.nih.gov/pubmed/26784872 http://dx.doi.org/10.3390/antiox3020288 |
Ejemplares similares
-
Phytochemical analysis, antioxidant and metal chelating capacity of Tetrapleura tetraptera
por: Adusei, Stephen, et al.
Publicado: (2019) -
Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments
por: Sales, Thais A., et al.
Publicado: (2019) -
Advances on Chelation and Chelator Metal Complexes in Medicine †
por: Kontoghiorghes, George J.
Publicado: (2020) -
Chelation in Metal Intoxication
por: Flora, Swaran J.S., et al.
Publicado: (2010) -
On the Anticataractogenic Effects of L-Carnosine: Is It Best Described as an Antioxidant, Metal-Chelating Agent or Glycation Inhibitor?
por: Abdelkader, Hamdy, et al.
Publicado: (2016)